Browse > Article

A Case of Rapid Improvement of Symptoms in Severe Guillain-Barr$\acute{e}$ Syndrome after Additional Use of Intravenous Immunoglobulin  

Kim, Doo Hyun (Department of Neurology, Yeungnam University College of Medicine)
Park, Min Su (Department of Neurology, Yeungnam University College of Medicine)
Publication Information
Annals of Clinical Neurophysiology / v.14, no.1, 2012 , pp. 49-51 More about this Journal
Keywords
Guillain-Barr$\acute{e}$ Syndrome; Intravenous immunoglobulin;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev 2010:CD002063.
2 van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC. IVIG treatment and prognosis in Guillain- Barre syndrome. J Clin Immunol 2010;30:S74-78.
3 Farcas P, Avnun L, Frisher S, Herishanu YO, Wirguin I. Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-BarrE syndrome. Lancet 1997;350:1747.
4 Kuitwaard K, de Gelder J, Tio-Gillen AP, Hop WC, van Gelder T, van Toorenenbergen AW, et al. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann Neurol 2009;66:597-603.
5 Merkies IS, Schmitz PI, van der Meche FG, Samijn JP, van Doorn PA. Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry 2002;72:596-601.
6 Vedeler C, Wik E, Nyland H. The long-term prognosis of Guillain-Barre syndrome. Evaluation of prognostic factors including plasma exchange. Acta Neurologica Scand 1997;95: 298-302.
7 Seta T, Nagayama H, Katsura K, Hamamoto M, Araki T, Yokochi M, et al. Factors influencing outcome in Guillain-Barre Syndrome: comparison of plasma adsorption against other treatments. Clinical Neurol Neurosurg 2005;107:491-496.